Wildemann, Brigitte
Jarius, Sven
Lehmann, Lorenz H.
André, Florian
Frey, Norbert
Schnitzler, Paul
Jäger, Laura
Gumbinger, Christoph
Viehöver, Andrea
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 23 June 2021
Revised: 26 August 2021
Accepted: 26 August 2021
First Online: 7 October 2021
Change Date: 2 March 2022
Change Type: Update
Change Details: Open access funding note is missing. Funding note should be “Open Access funding enabled and organized by Projekt DEAL”.
Declarations
:
: BW received grants from the German Ministry of Education and Research, Deutsche Forschungsgemeinschaft, Dietmar Hopp Foundation and Klaus Tschira Foundation, grants and personal fees from Merck, Sanofi Genzyme, Novartis, and personal fees from Alexion, Bayer, Biogen, Teva; none related to this work. SJ reports no disclosures relevant to the article. NF received grants from the German Ministry of Education and Research, Deutsche Forschungsgemeinschaft, and personal fees from AstraZeneca, Bayer, Böhringer Ingelheim, Novartis; none related to this work. LHL has served on the advisory board for Daiichi Sankyio, Senaca, and Servier, as an external expert for AstraZeneca and received speakers’ honoraria from Novartis and MSD, none related to this work. AF reports no disclosures relevant to the article. PS reports no disclosures relevant to the article. LJ reports no disclosures relevant to the article. CG reports no disclosures relevant to the article. AV received speaker honoraria from Merck Serono GmbH and Roche Pharma AG.